ইব্রুতিনিব (936563-96-1)
Ibrutinib is a non-receptor Bruton's tyrosine kinase inhibitor approved for the treatment of relapsed chronic lymphocytic leukemia(CLL), mantle cell lymphoma (MCL) and WaldenstrÖm's Macroglobulinemia (WM). Product Name: Ibrutinib CAS No.: 936563-96-1 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C25H24N6O2 Molecular Weight: 440.5 Shelf Life: 2 Years Package: 25kg/drum
